The vaccine application continues for children between 5 and 11 years old in Salamanca – El Sol de Salamanca

With greater order, but continuing with the great participation of citizens, during the second day of the anticovid-19 vaccination day for children between 5 and 11 years old, the Lázaro Cárdenas gym, once again registered a huge queue, where it started with 12 thousand 910 doses.

Contrary to Thursday, where the Lázaro Cárdenas gym recorded an overflow of files that generated an outbreak of anger among the mothers of the families, this Friday the order shone while waiting for the application of the vaccine, as well as recording a good influx to enter the annex.

People from other municipalities gathered in Salamanca, such as Juventino Rosas, Cortázar, Villagrán, just to name a few, with the aim of bringing their children to have the second dose applied, as happened with Mrs Ana Laura, who arrived to train from 6:00 in the morning.

“Today is more orderly than yesterday, the line advances quickly only if there are many people, apart from that, I see things better than yesterday, today there are not many people who get involved (…) I come from Juventino Rosas and I arrive at 6:00 in the morning to train and have taken my two children to complete their vaccination program “She said.

According to the cut of the Secretary of Health of Guanajuato, corresponding to 20:00 on Thursday, 8 thousand 90 doses had been applied, so for this Friday it started with 12 thousand 910, which means that the total of vaccines received to immunize this sector is of 21 thousand.

➡️Subscribe to our digital edition

In the last two years, 10 million 421 thousand 307 vaccines have been applied to the entire population of Guanajuato, with which progress is being made in the immunization of the population and in the fight against covid-19.

It should be noted that for the age group from 5 to 11 years of age, the Pfizer-BioNtec vaccine is applied, authorized in Mexico by the Federal Commission for the Prevention of Health Risks (COFEPRIS) at the beginning of March 2022.

–